Moreover, TRIB2 levels appear to correlate with many neoplasia conditions, conferring TRIB2 a role as a biomarker, which in contexts such as melanoma is even dependent on cancer stage progression and prognosis. The gene discussed is TRIB2; the disease is melanoma.